DC
BIVIW

Diametric Capital’s BioVie Inc Warrant BIVIW Stock Holding History

Diametric Capital’s Portfolio BIVIW Stock Details BIVIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233K Hold
750,000
– – 0.06% 371
2025
Q4 		$203K Hold
750,000
– – 0.05% 348
2025
Q3 		$345K Buy
+750,000
New +$305K 0.13% 214

Other funds holding BIVIW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Diametric Capital's BIVIW Position: Q1 2026 in Review

Diametric Capital held its BioVie Inc Warrant (BIVIW) position steady in Q1 2026 at 750,000 shares worth $233K. The position accounts for 0.06% of the portfolio, ranked #371.

Diametric Capital first reported a position in BIVIW in Q3 2025 and has held it in 3 quarters since. The position peaked at $345K in Q3 2025. 8 funds tracked by Wall St. Rank hold BIVIW as of Q1 2026.

  • Diametric Capital held 750,000 shares of BioVie Inc Warrant worth $233K as of Q1 2026.
  • Diametric Capital left its BioVie Inc Warrant share count unchanged in Q1 2026.
  • BioVie Inc Warrant made up 0.06% of Diametric Capital's portfolio in Q1 2026, its #371 holding.
  • Diametric Capital first reported a position in BioVie Inc Warrant in Q3 2025 and has held it in 3 quarters since.
  • Diametric Capital's BioVie Inc Warrant position peaked at $345K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held BioVie Inc Warrant as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.